European Journal of Rheumatology
Letter to the Editor

Remembering visceral leishmaniasis as a potential trigger of haemophagocytic lymphohistiocytosis in individuals treated with anti-TNF-alpha therapy

1.

Department of Haematology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark

2.

Department of Haematology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark; Department of Nephrology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark

3.

Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark

4.

Department of Haematology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark; Department of Rheumatology, Rigshospitalet, Institute for Inflammation Research, Copenhagen University Hospital, Copenhagen, Denmark

Eur J Rheumatol 2019; 6: 226-227
DOI: 10.5152/eurjrheum.2019.18178
Read: 222 Downloads: 85 Published: 16 October 2019

Cite this article as: Nardo-Marino A, Bukan K, Vedel Nielsen H, El Fassi D. Remembering visceral leishmaniasis as a potential trigger of haemophagocytic lymphohistiocytosis in individuals treated with anti-TNF-alpha therapy. Eur J Rheumatol 2019; 6(4): 226-7.

Files
ISSN2147-9720 EISSN 2148-4279